Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SKAN Group AGFRA:7VG +3.01%85 EV-to-OCF is 26.03 as of Aug. 25, 2026, which is 23% below its 10-year median of 33.98. GuruFocus rates FRA:7VG with a GF Score™ of 85/100 and a GF Value™ of €82.64. The stock has 7 warning signs investors should review. Among 851 Medical Devices & Instruments companies, SKAN Group AG ranks worse than 80.73% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, SKAN Group AG's Enterprise Value is €1,619.8 Mil.
SKAN Group AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €62.2 Mil. Therefore, SKAN Group AG's EV-to-OCF for today is 26.03.
The historical rank and industry rank for SKAN Group AG's EV-to-OCF or its related term are showing as below:
FRA:7VG'
s EV-to-OCF Range Over the Past 10 Years
Min: 15.66 Med: 33.98 Max: 211.71
Current: 26.19
During the past 6 years, the highest EV-to-OCF of SKAN Group AG was 211.71. The lowest was 15.66. And the median was 33.98.
FRA:7VG's EV-to-OCF is ranked worse than 80.73% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.78
vs FRA:7VG: 26.19
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SKAN Group AG's PE Ratio (TTM) for today is calculated as:
SKAN Group AG's share price for today is €68.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SKAN Group AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was €1.428.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SKAN Group AG EV-to-OCF Related Terms
SKAN Group AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, SKAN Group AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's EV-to-OCF falls into.
SKAN Group AG's current Enterprise Value is €1,619.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. SKAN Group AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €62.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (FRA:7VG) has a EV-to-OCF of 26.03 as of Aug. 25, 2026. This is 23% below median its historical median of 33.98. Over the past decade, SKAN Group AG's EV-to-OCF has ranged from 15.66 to 211.71. According to the industry distribution chart, SKAN Group AG ranks #687 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 80.7%.
Is SKAN Group AG's EV-to-OCF too high?
SKAN Group AG's current EV-to-OCF of 26.03 is 23% below median its 10-year median of 33.98. Over the past 10 years, this metric has ranged from a low of 15.66 to a high of 211.71. The Medical Devices & Instruments industry median EV-to-OCF is 7.78. SKAN Group AG's value of 26.03 is 234.6% above this industry median. Based on the distribution chart, SKAN Group AG ranks #687 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SKAN Group AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #687 out of 851 companies for EV-to-OCF. This places SKAN Group AG in the lower half of its industry. The industry median EV-to-OCF is 7.78. SKAN Group AG's value of 26.03 is 234.6% above this benchmark. Historically, SKAN Group AG's own EV-to-OCF has ranged from 15.66 to 211.71 over the past decade. While the company's 10-year median is 33.98 vs. the industry median of 7.78, SKAN Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.78, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SKAN Group AG's current EV-to-OCF of 26.03 is 234.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current EV-to-OCF is 26.03, which is 23% below median its own 10-year median of 33.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
SKAN Group AG (FRA:7VG) has a current EV-to-OCF of 26.03. The stock's GF Value™ is €82.64, compared to a current price of €68.50 — trading 17.1% below its estimated fair value. The current EV-to-OCF is 26.03, which is 23% below median its 10-year median of 33.98 and 234.6% above the Medical Devices & Instruments industry median of 7.78. SKAN Group AG's overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current EV-to-OCF is 26.03 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (FRA:7VG) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of €68.50 is trading 17.1% below its estimated GF Value™ of €82.64.
Key valuation signals for FRA:7VG:
EV-to-OCF: 26.03 (23% below median its 10-year median of 33.98)
GF Value™: €82.64 vs. price of €68.50 (17.1% below fair value)
Industry Position: 234.6% above the Medical Devices & Instruments median (#687 of 851)
No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
85GF Score
Get the complete analysis for FRA:7VG
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7VG has been successfully added to your 
